Abstract: For preparing fluorinated quinolone antibiotic medicine locally used in stomatology, simultaneous determination of norfloxacin, ciprofloxacin, and enoxacin was carried out by multiphase ion chromatography with fluorescence detection. Quinolone antibiotics were separated by Dionex OmniPac PAX-500 column with an eluent of 15 mmol/L H 2 SO 4 and 35% methanol (v/v) at a flow-rate of 1.0 ml/min and detected with fluorescence with excitation and emission wave lengths of 347 nm and 420 nm respectively. The detection limits (S/N=3) of norfloxacin, ciprofloxacin and enoxacin were 50, 105 and 80 ng/ml respectively. The relative standard deviations of retention time, peak area and peak height were less than 1.1% and good linear relationship resulted. The developed method was applied to pharmaceutical formulations and biological fluids.
INTRODUCTION
Most antimicrobial agents introduced for clinical use in recent years are nalidixic acid derivatives. Their common skeleton is termed 4-oxo-1,4-dihydroguionoline. These medicines (Fig.1 ) are, however, better known under their generic name, 4-quinolones. These compounds act directly on bacterial DNA by inhibiting topoisomerase which leads to cell death, so they are bactericidal (Appelbaum and Hunter, 2000; Bryskier and Chantot, 1995; Asahina et al., 1992; Morissey et al., 1996) . These agents are widely used in clinical applications and in the treatment and prevention of oral ulcers and periodontitis with obvious effects (Yang et al., 1997; Duan et al., 2002) . In order to prepare a new compound medicine, it is necessary to analyse fluorinated quinolone antibacterials. The methods available for fluorinated quinolone antibacterials assays are thin-layer chromatography (TLC)-fluorescence (Simonovska et al., 1999; Novakovic et al., 2001; Riesbeck and Forsgren, 1994) , capillary electrophoresis-UV or fluorescence (Faria et al., 2006; Awadallah et al., 2003; Schmitt-Kopplin et al., 1999) , high-performance liquid chromatography (HPLC)-UV or fluorescence (Grellet et al., 2002; Carlucci, 1998; Gasparrini et al., 2001; Lee and Hong, 2000; Brodfuehrer et al., 1998) . The majority of these methods were developed to analyse fluorinated quinolone antibacterials in biological samples such as serum or urine, residues in fish and meat or medicine tablets.
As most of the fluorinated quinolone antibacterials are quinolinecarboxylic acids, they can be separated by anion exchange chromatography and detected by fluorescence detection. In this paper, a novel analysis system to determine three fluorinated quinolone antibacterials simultaneously was developed by using ion chromatography with multi-phase ion chromatography and fluorescence detection.
EXPERIMENT

Chemicals and reagents
Methanol was HPLC-grade, and H 2 SO 4 was analytical-reagent grade (purchased from Shanghai Chemical Reagents, Shanghai, China). Norfloxcin, ciprofloxacin and enoxacin were biochemical reagents (purchased from Shanghai Chemical Reagents, Shanghai, China).
Apparatus
The chromatographic system consisted of a Dionex 4000I ion chromatograph pump (Sunnyvale, CA, USA) equipped with Rheodyne-7125 injection valve (Rheodyne, Cotati, CA, USA) and Shimadzu RF-535 fluorescence detector (Shimadzu, Kyoto, Japan). Dionex OmniPac PAX-500 (250 mm×4.6 mm) column. Data plotting and analysis were done with Yingpu chromatographic data station (Yingpu, Hangzhou, Zhejiang, China) software installed on a PII computer.
Chromatographic conditions
The mobile phase consisted of a mixture of 35% methanol (v/v) and 15 mmol/L H 2 SO 4 . The eluent was carefully degassed and filtered prior to use at a flow-rate of 1 ml/min. The injection volume was 50 µl. Detection was performed at excitation wavelength of 347 nm and emission wavelength of 420 nm.
Standard solutions
A stock solution of fluorinated quinolone was prepared to 1 mg/ml with methanol. This solution was stored at 4 °C for no longer than two months.
Standard work solutions were prepared every day, and diluted with distilled water.
Procedure
Samples were dissolved in distilled water, adjusted into the concentration range of 1 to 20 µg/ml and filtered with 0.45 µm membrane filter and then injected directly.
RESULTS AND DISCUSSION
Optimization of the wavelength for fluorescence detection
The optimal wavelength for simultaneous detection of three fluorinated quinolone antibacterials was observed. As shown in Fig.2 , it was found that the excitation wavelength of 347 nm and emission wavelength of 420 nm were the most suitable for detection of the three fluorinated quinolone antibacterials simultaneously.
Optimization of the separation
The separation of the fluorinated quinolone antibacterials was achieved using a multi-phase stationary phase which combines anion exchange and reversed-phase mechanisms with mixtures of sulfuric acid and methanol as eluent. The role of the sulfuric acid was to protonate the analytes and to also provide 2 4 SO − as the eluent competing ion. The methanol was added to reduce hydrophobic absorption of the analytes and to decrease the retention times. With the elution of 0.05 mol/L H 2 SO 4 , the relationship of retention time and resolution with different concentrations of methanol is shown in Table 1 and Fig.3 .
Judging from the experimental results, the retention time of the analyte was suitable and resolution was also good when the concentration of methanol was 35% (v/v), so eluent containing 35% (v/v) methanol was chosen in the experiments.
With the concentration of methanol set at 35% (v/v), the relationship of retention time and resolution with the different concentration of H 2 SO 4 is shown in Table 2 and Fig.4. The concentration of H 2 SO 4 set at 0.015 mol/L was considered to be suitable for detection of the three fluorinated quinolones. In the above-mentioned experimental conditions, the resolution of each fluorinated quinolone was more than 1, and the retention time of the analyte was as expected appropriate.
So eluent containing 35% (v/v) methanol and 0.015 mol/L H 2 SO 4 was chosen in the experiments for the simultaneous determination of the three fluorinated quinolone antibacterials.
Calibration, limit of detection
A calibration curve was described by the equation A(H)=mx+b, where A(H) represents the response value of the analyte in the sample (peak area or peak height). The x in the equation represents the concentration of µg/ml of each fluorinated quinolone injected into the column. The mean correlation coefficient, intercept and slope values of all the three quinolones tested are indicated in Table 3 . The chroma- tographic method was demonstrated to be linear from 1 to 100 µg/ml of each fluorinated quinolone injected (r≥0.9995).
The lower detection limit for each fluorinated quinolone was determined by analysing calibration standards from 20 to 200 ng/ml of each fluorinated quinolone injected. The detection limits (S/N=3) of norfloxacin, ciprofloxacin and enoxacin were 50, 105 and 80 ng/ml, respectively. Fig.5 shows a typical chromatogram of the standard stock solution containing norfloxacin, ciprofloxacin and enoxacin.
Repeatability
Precision studies for 10 replicate injections of 5 µg/ml standard stock solution of the three fluorinated quinolones gave the percentage relative standard deviations of the three analytes in the range of 0.85%~1.0% for retention time, 0.73%~1.2% for peak area, and 0.63%~0.96% for peak height.
Application
The method described above was successfully applied for direct analysis of the mixed diluent solutions of norfloxacin and ciprofloxacin in pharmaceutical formulations. The recoveries of norfloxacin and ciprofloxacin were calculated by comparison of peak heights of the injected standards. The recoveries were in the range 100.1% to 103.5% when standard 0.42 µg/ml norfloxacin and 8.6 µg/ml ciprofloxacin were spiked into the sample for nine injections. Results are shown in Table 4 . Fig.6 shows the chromatogram from the analysis of diluent solutions of pharmaceutical formulations.
The developed method was used for qualitative measurement of the fluorinated quinolones from human urine. As the half-life of ciprofloxacin was 3 to 4 h, measurements of the diluted human urine (1:100) of patient given oral dose of 0.25 g for 4 h were performed. Fig.7 shows the chromatogram from diluted human urine. 
CONCLUSION
A rapid and convenient procedure for separating and detecting the fluorinated quinolone antibacterials simultaneously has been developed and validated by ion chromatography-fluorescence detection. The method was stable and highly sensitive, so it may be applicable for monitoring fluorinated quinolone antibacterials in human body and biological tissues.
